Cargando…
Refining clinical trial inclusion criteria to optimize the standardized response mean of the CMTPedS
The CMT Pediatric Scale (CMTPedS) is a reliable, valid, and responsive clinical outcome measure of disability in children with CMT. The aim of this study was to identify the most responsive patient subset(s), based on the standardized response mean (SRM), to optimize the CMTPedS as a primary outcome...
Autores principales: | Cornett, Kayla M. D., Menezes, Manoj P., Bray, Paula, Shy, Rosemary R., Moroni, Isabella, Pagliano, Emanuela, Pareyson, Davide, Estilow, Tim, Yum, Sabrina W., Bhandari, Trupti, Muntoni, Francesco, Laura, Matilde, Reilly, Mary M., Finkel, Richard S., Eichinger, Katy J., Herrmann, David N., Shy, Michael E., Burns, Joshua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7480902/ https://www.ncbi.nlm.nih.gov/pubmed/32762141 http://dx.doi.org/10.1002/acn3.51145 |
Ejemplares similares
-
Development, reliability and validity of the Charcot-Marie-Tooth disease Pediatric Scale (CMTPedS)
por: Burns, Joshua, et al.
Publicado: (2011) -
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
por: Fridman, V, et al.
Publicado: (2015) -
Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A
por: Eichinger, Katy, et al.
Publicado: (2022) -
Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre study
por: Pipis, Menelaos, et al.
Publicado: (2021) -
Cross-sectional analysis of a large cohort with X-linked Charcot-Marie-Tooth disease (CMTX1)
por: Panosyan, Francis B., et al.
Publicado: (2017)